跳至主要内容
临床试验/EUCTR2013-003828-36-SK
EUCTR2013-003828-36-SK进行中(未招募)1 期

A multicentre, open-label, extension study, evaluating the safety and tolerability and the efficacy of ADV7103 at long term in distal renal tubular acidosis patients.

Advicenne Pharma0 个研究点目标入组 24 人开始时间: 2015年8月27日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Subject who has participated to and completed the previous Advicenne clinical Study B21CS.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 18
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 6
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Subject who has not participated to Advicenne clinical Study B21CS
  • Subject for whom any safety issue could contraindicate her/his participation to the extension study.

研究者

发起方
Advicenne Pharma

相似试验